Patient Observation Record
Patient Information:
   Patient Name: Mr. Ramesh Patel
   Age/Gender: 52 years/male
   MRN: 102456
   Date of Visit: July 1st, 2025
   Consulting Physician: Dr. Anjali Desai, Diabetologist
Presenting Complaints:
   Generalized fatigue
   Increased thirst and urination
   Blurred vision intermittently
   Occasional tingling in feet
History of Present Illness:
   Type 2 diabetes diagnosed 5 years ago.
   Previously on oral therapy with suboptimal control.
   No recent hospitalizations.
   Occasional dietary indiscretions reported.
Past Medical History:
   Hypertension x 8 years
   Dyslipidemia x 5 years
   No known C.D., no stroke
   No history of diabetic foot ulcers
Medications:
   Current Rx:
       Metformin 1000 mg twice daily
       Glimepiride 2 mg once daily
       Atorvastatin 20 mg once daily HS
       Telmisartan 40 mg once daily
Clinical Examination:
   Weight: 82 kg
   Height: 168 cm
   BMI: 29.0 kg/mÂ² (Overweight)
   BP: 138/82 mmHg
   Pulse: 78 per minute
   Foot examination: Normal sensation, no ulcers
   Eye examination: Mild non-proliferative diabetic retinopathy noted
   Cardiovascular/Chest exam: Normal
   Neurological exam: Mild peripheral sensory neuropathy in toes
   take fiber as supplement
Investigations Ordered (Lab Requisition):
   Fasting blood glucose
   Postprandial blood glucose
   HbA1c
   Serum creatinine
   eGFR
   Lipid profile
   Urine microalbumin
   TSH for hypothyroidism screen
   Complete blood count
   ECG screen for silent ischemia
Assessment:
   Type 2 diabetes mellitus with suboptimal glycemic control; HbA1c target not yet achieved.
   Mild diabetic peripheral neuropathy.
   Hypertension: Stable on current therapy.
   Dyslipidemia: On statin therapy.
Plan and New Prescription:
   Medication Adjustments:
       Switch from Glimepiride 2 mg OD to Glimepiride 4 mg OD.
       Add Empagliflozin 10 mg once daily.
   Lifestyle Advice:
       Reinforce diet plan with reduced refined carbohydrates.
       Encourage brisk walking at least 30 minutes daily.
   Footcare Education: Reinforced.
   Next Follow-up: 4 weeks with lab results.
